Population pharmacokinetic and dynamic models: parametric (P) and nonparametric (NP) approaches

With parametric (P) models, the probability distributions of each PK/PD (pharmacokinetic/pharmacodynamic) model parameter are described as means and covariances, as estimators of the central tendency and of the dispersion. With nonparametric (NP) models, however, no assumptions at all are made about the shape of the parameter distributions. This robust approach has the viewpoint that the best (ideal) population model would be the correct structural model, together with the entire collection of each subject's exactly-known parameter values, if it were somehow possible to know them. NP methods resolve the results into up to one set of parameter values for each subject, along with an estimated probability for each parameter set. The strength of the method is its ability to estimate the entire population parameter joint density with maximum likelihood. Optimal population modeling currently begins by determining the assay error pattern explicitly over its working range. Next, one currently uses a P population modeling method to separate intra- from inter-individual variability. One can then use this information in an NP approach to estimate the entire population parameter discrete joint density. NP models lend themselves naturally to "multiple model" (MM) dosage design for maximally precise regimens for optimal patient care.

[1]  Dimitri P. Bertsekas,et al.  Dynamic Programming: Deterministic and Stochastic Models , 1987 .

[2]  E. Vonesh,et al.  Mixed-effects nonlinear regression for unbalanced repeated measures. , 1992, Biometrics.

[3]  B. Lindsay.  The Geometry of Mixture Likelihoods: A General Theory , 1983 .

[4]  Leon Aarons.  The estimation of population pharmacokinetic parameters using an EM algorithm. , 1993, Computer methods and programs in biomedicine.

[5]  Adrian F. M. Smith,et al.  Bayesian Analysis of Linear and Non‐Linear Population Models by Using the Gibbs Sampler , 1994 .

[6]  A. Schumitzky.  Nonparametric EM Algorithms for estimating prior distributions , 1991 .

[7]  R. Jelliffe,et al.  Population Pharmacokinetic Models , 1993 .

[8]  D. Bates,et al.  Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.

[9]  Roger W. Jelliffe,et al.  Population pharmacokinetic/dynamic (PK/PD) modeling via the World Wide Web , 2001, Proceedings 14th IEEE Symposium on Computer-Based Medical Systems. CBMS 2001.

[10]  L B Sheiner,et al.  Forecasting individual pharmacokinetics , 1979, Clinical pharmacology and therapeutics.

[11]  Marie Davidian,et al.  The Nonlinear Mixed Effects Model with a Smooth Random Effects Density , 1993 .

[12]  A. Mallet.  A maximum likelihood estimation method for random coefficient regression models , 1986 .

[13]  Roger W. Jelliffe,et al.  An adaptive grid non-parametric approach to pharmacokinetic and dynamic (PK/PD) population models , 2001, Proceedings 14th IEEE Symposium on Computer-Based Medical Systems. CBMS 2001.

[14]  D Bayard,et al.  Achieving target goals most precisely using nonparametric compartmental models and "multiple model" design of dosage regimens. , 2000, Therapeutic drug monitoring.